First Trust Advisors L.P. > First Trust Exchange-Traded Fund VI
First Trust Nasdaq Pharmaceuticals ETF
$22.17M
Avg Monthly Net Assets
$20.44M
Total Assets
$10K
Total Liabilities
$20.43M
Net Assets
First Trust Nasdaq Pharmaceuticals ETF is an Exchange-Traded Fund in First Trust Exchange-Traded Fund VI
from First Trust Advisors L.P.,
based in Illinois,
United States of America.
The fund has one share class
and monthly net assets of $22.17M.
On August 23rd, 2024 it reported 52 holdings, the largest
being Pfizer Inc (7.6%), AbbVie Inc (7.1%) and Merck & Co Inc (7.1%).
Data provided by Fincoded.
Share Classes
| Name | Class/Contract ID | Exchange | Ticker | Monthly Returns (2 years) |
|---|---|---|---|---|
| First Trust Nasdaq Pharmaceuticals ETF | C000169747 | XNAS | FTXH |
Holdings
From latest NPORT-P, filed August 23rd, 2024 for period ending June 30th, 2024.
Historic holdings data available from Fincoded.
| Name | Profile | Category | Country | Value $USD | # Shares | % of Fund |
|---|---|---|---|---|---|---|
| AbbVie Inc | Long | Equity-common | US | $1M | 8K | 7.07 |
| ACADIA Pharmaceuticals Inc | Long | Equity-common | US | $72K | 4K | 0.35 |
| Alkermes PLC | Long | Equity-common | IE | $187K | 8K | 0.91 |
| Amgen Inc | Long | Equity-common | US | $846K | 3K | 4.14 |
| Arcellx Inc | Long | Equity-common | US | $104K | 2K | 0.51 |
| Arvinas Inc | Long | Equity-common | US | $60K | 2K | 0.29 |
| Beam Therapeutics Inc | Long | Equity-common | US | $61K | 3K | 0.30 |
| Biogen Inc | Long | Equity-common | US | $792K | 3K | 3.88 |
| BioMarin Pharmaceutical Inc | Long | Equity-common | US | $99K | 1K | 0.48 |
| Blueprint Medicines Corp | Long | Equity-common | US | $119K | 1K | 0.58 |
| Bristol-Myers Squibb Co | Long | Equity-common | US | $1M | 29K | 5.94 |
| Cardinal Health Inc | Long | Equity-common | US | $651K | 7K | 3.19 |
| Charles River Laboratories International Inc | Long | Equity-common | US | $359K | 2K | 1.76 |
| CRISPR Therapeutics AG | Long | Equity-common | CH | $66K | 1K | 0.33 |
| Dreyfus Government Cash Management | Long | Short-term investment vehicle | US | $20K | 20K | 0.10 |
| Elanco Animal Health Inc | Long | Equity-common | US | $149K | 10K | 0.73 |
| Eli Lilly & Co | Long | Equity-common | US | $891K | 984 | 4.36 |
| Exact Sciences Corp | Long | Equity-common | US | $76K | 2K | 0.37 |
| Exelixis Inc | Long | Equity-common | US | $182K | 8K | 0.89 |
| Gilead Sciences Inc | Long | Equity-common | US | $706K | 10K | 3.45 |
| GRAIL Inc | Long | Equity-common | US | $3K | 165 | 0.01 |
| Halozyme Therapeutics Inc | Long | Equity-common | US | $336K | 6K | 1.64 |
| Ideaya Biosciences Inc | Long | Equity-common | US | $81K | 2K | 0.40 |
| Illumina Inc | Long | Equity-common | US | $103K | 991 | 0.51 |
| Incyte Corp | Long | Equity-common | US | $216K | 4K | 1.06 |
| Intra-Cellular Therapies Inc | Long | Equity-common | US | $102K | 1K | 0.50 |
| Ionis Pharmaceuticals Inc | Long | Equity-common | US | $109K | 2K | 0.53 |
| Jazz Pharmaceuticals PLC | Long | Equity-common | US | $584K | 5K | 2.86 |
| Johnson & Johnson | Long | Equity-common | US | $1M | 9K | 6.57 |
| Krystal Biotech Inc | Long | Equity-common | US | $119K | 649 | 0.58 |
| Kymera Therapeutics Inc | Long | Equity-common | US | $72K | 2K | 0.35 |
| Medpace Holdings Inc | Long | Equity-common | US | $307K | 745 | 1.50 |
| Merck & Co Inc | Long | Equity-common | US | $1M | 12K | 7.07 |
| Merus NV | Long | Equity-common | NL | $126K | 2K | 0.62 |
| MoonLake Immunotherapeutics | Long | Equity-common | CH | $94K | 2K | 0.46 |
| Neurocrine Biosciences Inc | Long | Equity-common | US | $177K | 1K | 0.87 |
| Nuvalent Inc | Long | Equity-common | US | $93K | 1K | 0.46 |
| Organon & Co | Long | Equity-common | US | $608K | 29K | 2.97 |
| Perrigo Co PLC | Long | Equity-common | IE | $244K | 9K | 1.19 |
| Pfizer Inc | Long | Equity-common | US | $2M | 56K | 7.65 |
| Prestige Consumer Healthcare Inc | Long | Equity-common | US | $161K | 2K | 0.79 |
| Regeneron Pharmaceuticals Inc | Long | Equity-common | US | $806K | 767 | 3.95 |
| Rhythm Pharmaceuticals Inc | Long | Equity-common | US | $98K | 2K | 0.48 |
| Roivant Sciences Ltd | Long | Equity-common | US | $96K | 9K | 0.47 |
| Sarepta Therapeutics Inc | Long | Equity-common | US | $128K | 810 | 0.63 |
| TG Therapeutics Inc | Long | Equity-common | US | $107K | 6K | 0.52 |
| Ultragenyx Pharmaceutical Inc | Long | Equity-common | US | $82K | 2K | 0.40 |
| United Therapeutics Corp | Long | Equity-common | US | $949K | 3K | 4.64 |
| Vertex Pharmaceuticals Inc | Long | Equity-common | US | $826K | 2K | 4.04 |
| Viatris Inc | Long | Equity-common | US | $637K | 60K | 3.12 |
| Viking Therapeutics Inc | Long | Equity-common | US | $71K | 1K | 0.35 |
| Zoetis Inc | Long | Equity-common | US | $648K | 4K | 3.17 |
Address
First Trust Exchange-Traded Fund VI
120 East Liberty Drive
Suite 400
Wheaton
Illinois
60187
United States of America
Websites
Directors
Bronwyn Wright
Denise M. Keefe
James A. Bowen
Niel B. Nielson
Richard E. Erickson
Robert F. Keith
Thomas R. Kadlec
Transfer Agents
Brown Brothers Harriman & Co.
The Bank of New York Mellon
Pricing Services
Bloomberg L.P.
ICE Data Pricing & Reference Data, LLC
LSEG Pricing Service
Custodians
Banco Santander Chile
Bank Polska Kasa Opieki S.A.
Brown Brothers Harriman & Co.
Citibanamex, Mexico City
Citibank Europe PLC (Czech Republic)
Citibank Europe PLC, Hungarian Branch Office
Citibank N.A., Brazilian Branch
Citibank ZAO
Deutsche Bank AG Mumbai
Deutsche Bank AG, Jakarta
Deutsche Bank, Istanbul
Euroclear Bank SA/NV (Belgium)
HSBC Bank (Taiwan) Limited
HSBC Bank Egypt
STANDARD CHARTERED BANK (SINGAPORE) LIMITED
Standard Chartered Bank (Johannesburg, ZA Branch)
Standard Chartered Bank Malaysia Berhad
Standard Chartered Bank, Philippines Branch
The Bank of New York Mellon
The Hongkong and Shanghai Banking Corporation (Hong Kong)
The Hongkong and Shanghai Banking Corporation Limited, Bangkok Branch
Shareholder Servicing Agents
Brown Brothers Harriman & Co.
The Bank of New York Mellon
Admins
Brown Brothers Harriman & Co.
The Bank of New York Mellon
Brokers
J.P. MORGAN SECURITIES LLC
GOLDMAN SACHS & CO. LLC
UBS Securities LLC
BTG PACTUAL US CAPITAL, LLC
LarrainVial Securities US LLC
BOFA SECURITIES, INC.